Understanding HIV viral load: Implications for counselling

Canadian Journal of Public Health

Volumn 99, Issue 3, 2008, Pages 189-191

  O'Byrne, Patrick ^a   MacPherson, Paul A ^b,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Blood; Counseling; HIV; Prevention; Semen; Viral load

Indexed keywords

CANADA; COUNSELING; DISEASE TRANSMISSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; REVIEW; SPERM; VIROLOGY; VIRUS LOAD;

CANADA; COUNSELING; FEMALE; HIV INFECTIONS; HUMANS; MALE; SEMEN; VIRAL LOAD;

EID: 46149127114     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03405471     Document Type: Review

References (30)

1. HIV and AIDS in Canada. Surveillance Report to June 30, 2006. Surveillance and Risk Assessment Division, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada, 2006.
2. 2004 Canadian Sexually Transmitted Infections Surveillance Report. Can Commun Dis Rep 2007;33(Suppl. 1):1-69.
3. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2005. Vol. 17. Rev ed. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2007.
4. HIV/AIDS, Viral Hepatitis and Sexually: Transmitted Infections in Australia, Annual Surveillance Report. National Centre in HIV Epidemiology and Clinical Research, 2006.
5. Crepaz N, Hart TA, Marks G. Highly active antiretroviral therapy and sexual risk behavior: A meta-analytic review. JAMA 2004;292(2):224-36.
6. Dukers NH, Goudsmit J, de Wit JB, Prins M, Weverling GJ, Coutinho RA. Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection. AIDS 2001;15(3):369-78.
7. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000;342(13):921-29.
8. Chakraborty H, Sen PK, Helms RW, Vernazza PL, Fiscus SA, Eron JJ, et al. Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: A probabilistic empiric model. AIDS 2001;15(5):621-27.
9. Vernazza ML, Troiani L, Flepp MJ, Cone RW, Schock J, Roth F, et al. Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study. AIDS 2000;14(2):117-21.
10. Kalichman SC, Cage M, Barnett T, Tharnish P, Rompa D, Austin J, et al. Human immunodeficiency virus in semen and plasma: Investigation of sexual transmission risk behavioral correlates. AIDS Res Hum Retroviruses 2001;17(18):1695-703.
11. Barroso PF, Schechter M, Gupta P, Bressan C, Bomfim A, Harrison LH. Adherence to antiretroviral therapy and persistence of HIV RNA in semen. J Acquir Immune Defic Syndr 2003;32(4):435-40.
12. Dornadula G, Zhang H, VanUitert B, Stern J, Livornese L, Ingerman MJ, et al. Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy. JAMA 1999;282(17):1627-32.
13. Leruez-Ville M, Dulioust E, Costabliola D, Salmon D, Tachet A, et al. Decrease in HIV-1 seminal shedding in men receiving highly active antiretroviral therapy: An 18 month longitudinal study (ANRS EP012). AIDS 2002;16(3):486-88.
14. Fiore JR, Suligoi B, Saracino A, Di Stefano M, Bugarini R, Lepera A, et al. Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies. AIDS 2003;17(15):2169-76.
15. García-Bujalance S, Ruiz G, Guevara CL, Peña JM, Bates I, Vázquez JJ, et al. Quantitation of human immunodeficiency virus type 1 RNA loads in cervicovaginal secretions in pregnant women and relationship between viral loads in the genital tract and blood. Eur J Clin Microbiol Infect Dis 2004;23(2):111-15.
16. Bujan L, Daudin M, Matsuda T, Righi L, Thauvin L, Berges L, et al. Factors of intermittent HIV-1 excretion in semen and efficiency of sperm processing in obtaining spermatozoa without HIV-1 genomes. AIDS 2004;18(5):757-66.
17. Chan DJ. Pathophysiology of HIV-1 in semen: Current evidence for compartmentalisation and penetration by antiretroviral drugs. Curr HIV Res 2005;3(3):207-22.
18. Lafeuillade A, Solas C, Halfon P, Chadapaud S, Hittinger G, Lacarelle B. Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: Clinical correlations. HIV Clin Trials 2002;3(1):27-35.
19. Sankatsing SUC, Droste J, Burger D, van Praag RME, Jurriaans S, Lange JMA, et al. Limited penetration of lopinavir into seminal plasma of HIV-1-infected men. AIDS 2002;16(12):1698-700.
20. Craigo JK, Patterson BK, Paranjpe S, Kulka K, Ding M, Mellors J, et al. Persistent HIV type 1 infection in semen and blood compartments in patients after long-term potent antiretroviral therapy. AIDS Res Hum Retroviruses 2004;20(11):1196-209.
21. Pinto Neto LF, Vieira NF, Soprani M, Cunha CB, Cabral VP, Dietze R, et al. Longitudinal comparison between plasma and seminal HIV-1 viral loads during antiretroviral treatment. Rev Soc Bras Med Trop 2003;36(6):689-94.
22. Cohen MS, Hoffman IF, Royce RA, Kazembe P, Dyer JR, Costello Daly C, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: Implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet 1997;349(9069):1868-73.
23. Sadiq AT, Taylor S, Kaye S, Bennett J, Johnstone R, Byrne P, et al. The effects of antiretroviral therapy on HIV-1 RNA loads in seminal plasma in HIV-positive patients with and without urethritis. AIDS 2002;16(2):219-25.
24. Blankson JN, Persaud D, Siliciano RF. The challenge of viral reservoirs in HIV-1 infection. Annu Rev Med 2002;53:557-93.
25. Coombs RW, Speck CE, Hughes JP, Lee W, Sampoleo R, Ross SO, et al. Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: Evidence for compartmentalization of HIV-1 between semen and blood. J Inféct Dis 1998;177(2):320-30.
26. De Pasquale MP, Leigh Brown AJ, Uvin SC, Allega-Ingersoll J, Caliendo AM, Sutton L, et al. Differences in HIV-1 pol sequences from female genital tract and blood during antiretroviral therapy. J Acquir Immune Defic Syndr 2003;34(1):37-44.
27. Kiessling AA, Fitzgerald LM, Zhang D, Chhay H, Brettler D, Eyre RC, et al. Human immuno-deficiency vírus in semen arises from a genetically distinct virus reservoir. AIDS Res Hum Retroviruses 1998;14(Suppl 1):S33-S41.
28. Gupta P, Leroux C, Patterson BK, Kingsley L, Rinaldo C, Ding M, et al. Human immunodeficiency virus type 1 shedding pattern in semen correlates with the compartmentalization of viral Quasi species between blood and semen. J Infict Dis 2000;182(1):79-87.
29. Di Mascio M, Markowitz M, Louie M, Hogan C, Hurley A, Chung C, et al. Viral blip dynamics during highly active antiretroviral therapy. J Virol 2003;77(22):12165-72.
30. Disclosure of HIV Status After Currier: Resources for Community Based AIDS Organizations. Ottawa, ON: Canadian AIDS Society, 2004.